Trial Site Detail
Drug: |
Perifosine + Sunitinib |
|||
|---|---|---|---|---|
Trial: |
Perifosine + Sunitinib Malate for Patients With Advanced Cancers |
|||
| Conditions: | Renal Cancer; GIST | |||
Trial Status: |
Completed |
|||
Wilshire Oncology Medical Group |
Principal Investigator: |
|
|---|---|
Contact: |
415-946-2410, ocogtrials@ocog.net |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Wilshire Oncology Medical Group Website: |
http://www.womgi.com/content.aspx?section=clinicaltrials&id=30693 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.